Transthyretin (TTR) drugs for Transthyretin Amyloidosis with Polyneuropathy
5 tracked Transthyretin (TTR) drugs in the Transthyretin Amyloidosis with Polyneuropathy race. The class explanation lives on the Transthyretin (TTR) page; the full indication pipeline across every mechanism is on the Transthyretin Amyloidosis with Polyneuropathy page.
3 approved / phase 41 Phase 31 US approval withdrawn
Head-to-head evidence: Eplontersen vs Inotersen · Eplontersen vs Nucresiran · Eplontersen vs Patisiran · Eplontersen vs Vutrisiran · Inotersen vs Nucresiran · Inotersen vs Patisiran